[3eb7988a1663]

  - New candidate drug molecules identified by pharmaceutical companies through AI;
  - New alloy formulas discovered by material laboratories;
  - Optimized circuit architectures developed by chip design teams;
  - Even new products incubated by startups based on AI-generated ideas.

This will tank adoption in high tech fields that live and die by IP.

[anilgulecha]

No, for every established company that may be hesitant, there's up and comer with nothing to lose who will jump on the opportunity, and the industry will continue moving forward.

This is not a capability that will go unused.